While prognoses for prostate cancer patients were once measured in months, experts say that advances in treatment and diagnosis now improve survival by years.

The voluntary recall was prompted after routine testing. It is the second such recall recently of baby food over possible lead contamination.

The procedure could be life-changing for some people with debilitating conditions.

The agency narrowed who can get the shot and added new study requirements that could cost the company tens of millions.

So-called transient ischemic attacks can eventually lead to cognitive declines as steep as those following a full-on stroke, new research finds.

Trump aides have discussed requiring insurers to cover the procedure, though one leading medical group says it has been shut out of the process.

The Netflix series, which follows a group of autistic people as they search for love in their hometowns, feels good to watch, but don’t just call it feel-good TV.

New vaccines are often evaluated in trials in which some participants receive a placebo. But not all studies can be designed this way.

The most extensive research on Medicaid coverage to date found that it reduced the risk of death by 21 percent.

The Danish drugmaker, which makes Ozempic and Wegovy, has seen its stock tumble as competition in the weight-loss drug market has grown fiercer.

Disturbing thoughts and social fixations are among the many manifestations of obsessive-compulsive disorder.

With new testing requirements, it’s not even clear how new Covid or flu shots can be made available this fall.

Restrictions on payments to foreign partners may jeopardize studies of cancer and other conditions that would benefit Americans.

The technique used on a 9½-month-old boy with a rare condition has the potential to help people with thousands of other uncommon genetic diseases.